Tetanus: classify Clostridium, describe the pathogenesis and laboratory diagnosis of tetanus, and prophylaxis/prevention

Reading File

Finding Sources

Searching Images

tetanus Clostridium tetani pathogenesis toxin

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have all the information needed to write a comprehensive, well-cited answer. Let me compile it:

Tetanus: A Comprehensive Review

1. Classification of Clostridium

Clostridium is a large genus of obligate anaerobic, gram-positive, spore-forming bacilli. The key genus characteristics are:

Feature	Detail
Gram stain	Gram-positive rods (may appear gram-variable in older cultures)
Metabolism	Obligate (strict) anaerobes
Spores	Subterminal or terminal endospores; resistant to heat, drying, and many disinfectants
Motility	Most species are motile (peritrichous flagella); C. tetani is motile
Capsule	Generally non-encapsulated (C. tetani is nonencapsulated)
Toxin production	All pathogenic species are toxigenic

Medically important species and their diseases:

Species	Key Toxin	Primary Disease
C. tetani	Tetanospasmin (neurotoxin)	Tetanus
C. botulinum	Botulinum toxin (neurotoxin)	Botulism
C. perfringens	Alpha toxin (lecithinase/phospholipase C), enterotoxin	Gas gangrene (myonecrosis), food poisoning
C. difficile	Toxins A (enterotoxin) + B (cytotoxin)	Pseudomembranous colitis, antibiotic-associated diarrhea
C. septicum	Various toxins	Non-traumatic myonecrosis (associated with colon cancer)

C. tetani is distinguished by its terminal spore giving it a characteristic "drumstick" or "tennis racket" appearance, extreme oxygen sensitivity, and its single key virulence factor: tetanospasmin.

Medical Microbiology 9e, Trigger Words section: "Spore former, environmental, neurotoxin, contaminated wounds, tetanus, vaccine"

2. Pathogenesis of Tetanus

2a. The Organism

C. tetani is a motile, nonencapsulated, anaerobic gram-positive rod. It exists in two states:

Spore form - ubiquitous in soil and animal feces, survives in the environment for years, resistant to boiling and many disinfectants
Vegetative form - toxin-producing, requires anaerobic conditions to germinate from spores

Spores or bacteria enter through abrasions, wounds, open fractures, the umbilical stump (neonates), or injection drug use. About 20-30% of cases have no identifiable entry wound. Once in a wound with reduced tissue oxygen tension (due to devitalized tissue, foreign body, or co-infection), spores germinate into the toxin-producing vegetative form.

Harrison's 22E (2025), p. 1273

2b. Two Exotoxins

C. tetani produces two exotoxins:

Tetanolysin - a haemolysin that facilitates local growth of the bacterial population by destroying surrounding tissue
Tetanospasmin - the principal neurotoxin responsible for ALL clinical manifestations of tetanus; heat-labile

Tintinalli's Emergency Medicine, p. 1090

2c. Tetanospasmin: Structure and Transport

Tetanospasmin is produced as a single 150-kDa protein, then cleaved into:

Heavy chain (100 kDa) - binding and transport subunit
Light chain (50 kDa) - the active endopeptidase; linked by a disulfide bond

Mechanism of neural uptake and transport:

The carboxy-terminal of the heavy chain binds to specific membrane components (polysialogangliosides and membrane proteins) on the presynaptic alpha-motor nerve terminals at the neuromuscular junction
The toxin is internalized and undergoes retrograde intraneuronal transport - carried proximally up the motor axon to the motor neuron body in the ventral horn of the spinal cord or motor nuclei of cranial nerves
(Note: tetanospasmin does NOT cross the blood-brain barrier - it gains CNS access entirely through retrograde transport)
The toxin then translocates across the synapse to the GABAergic presynaptic inhibitory interneuron terminals
The light chain acts as a zinc-dependent endopeptidase that cleaves VAMP-2 (vesicle-associated membrane protein 2, also called synaptobrevin) - a molecule essential for docking and fusion of synaptic vesicles to the presynaptic membrane

Harrison's 22E, p. 1273

2d. Consequence: Loss of Inhibition

Cleavage of VAMP-2 blocks the release of inhibitory neurotransmitters - glycine and GABA (gamma-aminobutyric acid) - from presynaptic terminals. The result:

Motor neurons are released from inhibitory control → unregulated, excessive firing → sustained muscle contraction and spasms
Autonomic interneurons lose inhibitory control → preganglionic sympathetic overactivity → surges of catecholamines → tachycardia, labile hypertension, hyperpyrexia, sweating (autonomic nervous system dysfunction, ANSD)

Compare with Botulinum toxin: Both are A-B toxins; both bind sialic acid receptors on motor neurons; both are zinc-endopeptidases. The key difference - botulinum toxin stays at the neuromuscular junction and blocks acetylcholine release → flaccid paralysis; whereas tetanospasmin travels retrogradely to the spinal cord and blocks inhibitory neurotransmitters → spastic paralysis.

Medical Microbiology 9e, Case Study Answers; Tintinalli's, p. 1090

2e. Clinical Consequence

Short-axon (cranial) nerves are affected first → trismus (lockjaw), risus sardonicus (sardonic smile from facial muscle spasm), dysphagia
Descending spread → neck, trunk, extremities
Opisthotonus - severe arching of the whole body due to spasm of paravertebral and extensor muscles
Laryngospasm → apnoea → the most common cause of death
Autonomic dysfunction (2nd week): tachycardia, hypertension, sweating, hyperpyrexia
The incubation period is typically 7 days (range 4-14 days, up to 1 month); shorter incubation = more severe disease
Bailey & Love's Short Practice of Surgery 28th Ed.; Tintinalli's

2f. Types of Tetanus

Type	Description
Generalized	~80% of cases; descending pattern, trismus → opisthotonus
Localized	Rigidity confined to wound site; usually resolves; can progress to generalized
Cephalic	Follows head injury or otitis media; cranial nerve dysfunction (CN VII most common); poor prognosis
Neonatal	Generalized form in neonates; loss of suckling, poor feeding, generalised spasms; from unsterile umbilical cord care

3. Laboratory Diagnosis

Laboratory diagnosis of tetanus is largely clinical, as laboratory tests are of limited sensitivity and specificity.

3a. Clinical Diagnosis

The diagnosis is based on clinical findings: acute onset of hypertonia and/or painful muscle contractions (trismus, opisthotonus, generalized spasms) without other apparent cause. - Harrison's 22E, p. 1274; Medical Microbiology 9e

3b. Microbiological Tests (Low Sensitivity - Primarily to Support, Not Confirm)

Test	Notes
Microscopy	Useful if positive (gram-positive rods, may show terminal spore "drumstick" shape); generally organisms are not observed in the wound
Culture	Relatively insensitive - organisms are extremely oxygen-sensitive, making detection by anaerobic culture difficult; a positive wound culture does NOT confirm tetanus (organism can be present without disease)
Serology (anti-tetanus IgG)	Levels >0.1 IU/mL by ELISA are deemed protective and argue against tetanus; levels below this may support the diagnosis. However, antibodies to the toxin typically do not develop after natural infection because tetanospasmin is poorly immunogenic at disease-causing concentrations
Bioassay for serum tetanus toxin	Can be performed if antitoxin IgG is below threshold; a negative result does NOT exclude the diagnosis
PCR / Recombinase Polymerase Amplification (RPA)	To detect the tetanus neurotoxin gene; promising technique that has shown value in recent years

Harrison's 22E, p. 1274; Medical Microbiology 9e; Medical Microbiology 9e Case Answers

3c. Key Rule

"Diagnosis is based on clinical presentation and not laboratory tests. Microscopy and culture are insensitive, and neither tetanus toxin nor antibodies are typically detected." - Medical Microbiology 9e

3d. Differential Diagnosis to Exclude

Conditions that mimic tetanus include:

Strychnine poisoning
Dystonic reactions to antidopaminergic drugs (phenothiazines, metoclopramide)
Stiff-person syndrome
Neuroleptic malignant syndrome
Hypocalcaemic tetany
Peritonitis/acute abdomen (for abdominal rigidity)
Meningismus

The key distinguishing feature of tetanus: mental status remains normal (unless laryngospasm causes hypoxia). - Tintinalli's Emergency Medicine

4. Prophylaxis and Prevention

4a. Active Immunisation (Primary Prevention)

The tetanus vaccine uses tetanus toxoid (formalin-inactivated tetanospasmin), which is highly effective and safe. It is given in combination vaccines:

Vaccine	Combination	Use
DTaP	Diphtheria + Tetanus toxoids + acellular Pertussis	Primary series in children
Td	Tetanus + Diphtheria toxoids	Adult booster
Tdap	Tetanus + reduced diphtheria + acellular Pertussis	Adolescent/adult; preferred over Td if never received

Primary schedule: Three doses of tetanus toxoid (as DTaP in childhood), followed by booster doses every 10 years.

Important: Natural tetanus infection does NOT confer immunity (toxin is produced in concentrations too small to be immunogenic). All patients who develop tetanus must receive a full primary immunization course. - Medical Microbiology 9e; Harrison's 22E, p. 1275

4b. Wound Prophylaxis (Post-exposure)

Post-wound tetanus prophylaxis is based on two factors: (1) wound type and (2) patient's immunisation history.

Wound Classification:

Clean, minor wound - non-contaminated superficial wound
Tetanus-prone wound - contaminated (dirt, feces, soil, saliva), puncture wound, avulsion, missile/crush/burn/frostbite injury, >6 hours old, >1 cm deep, with devitalized tissue, or grossly contaminated

Decision Table:

Immunisation History	Clean, Minor Wound	Tetanus-Prone Wound
Unknown or <3 doses	Tetanus toxoid (Tdap preferred)	Tetanus toxoid (Tdap) AND TIG
≥3 doses, last booster <5 years	No toxoid needed	No toxoid needed
≥3 doses, last booster 5-10 years	No toxoid needed	Tetanus toxoid (booster)
≥3 doses, last booster >10 years	Tetanus toxoid (booster)	Tetanus toxoid (booster)

Miller's Review of Orthopaedics 9th Ed.; Pfenninger and Fowler's Procedures for Primary Care

4c. Passive Immunisation - Tetanus Immunoglobulin (TIG)

Human Tetanus Immunoglobulin (HTIG) - preparation of choice; fewer anaphylactoid reactions
- Post-exposure prophylaxis dose: 250 units IM (4 units/kg in children), single dose
- Treatment of established tetanus: 3,000-6,000 units IM
- Give before wound debridement (exotoxin may be released during manipulation)
- Neutralises circulating toxin and toxin in the wound but NOT toxin already fixed to nervous tissue
- Half-life is 28 days, so repeated doses are unnecessary
Equine antitoxin - alternative in low/middle-income countries; requires prior hypersensitivity testing; dose 10,000-20,000 units IM
Tintinalli's Emergency Medicine, p. 1091

Note: Toxoid and TIG should be given at separate injection sites when both are required simultaneously.

4d. Wound Management (Local Prophylaxis)

All wounds should receive thorough debridement to remove devitalized tissue, foreign bodies, and eliminate anaerobic conditions that favour toxin production. This is an essential component of prophylaxis and treatment.

Medical Microbiology 9e; Bailey & Love's Surgery 28th Ed.

4e. Treatment of Established Tetanus (Summary)

Intervention	Details
Wound debridement	Eliminate the toxin source
Antibiotics	Metronidazole 500 mg IV q6-8h (preferred); penicillin G is an alternative but theoretically can potentiate spasms (GABA antagonism)
Antitoxin (HTIG)	3,000-6,000 units IM, neutralise unbound toxin
Active immunisation	Tetanus toxoid at presentation, 6 weeks, and 6 months later
Airway control	Early tracheostomy in severe cases
Spasm control	Benzodiazepines (diazepam/midazolam); neuromuscular blockers if sedation alone fails
Autonomic dysfunction	Magnesium sulfate (2-4 mmol/L), labetalol, clonidine
ICU care	Minimal stimuli; mechanical ventilation; nutrition; DVT prophylaxis

Tintinalli's Emergency Medicine, Treatment Table; Harrison's 22E, p. 1275

Key Points to Remember

C. tetani is a non-invasive organism - it does not spread from the wound; all effects are due to the toxin
Tetanospasmin = A-B toxin - B chain binds gangliosides, A chain (zinc endopeptidase) cleaves VAMP-2/synaptobrevin
VAMP-2 cleavage → blocks GABA and glycine release → spastic paralysis (opposite of botulism which causes flaccid paralysis)
Disease does not confer immunity - always vaccinate after recovery
Lab diagnosis is clinical; culture and serology are unreliable
Prophylaxis requires assessing both wound type and vaccination history

This is a shared conversation. Sign in to Orris to start your own chat.